Medicine

Stefan Horn, B. Fehse

2024.5.15Innere Medizin

DOI: 10.1007/s00108-024-01711-5

tlooto Summary

Although gene therapy applications of AAV vectors are generally considered safe, the systemic administration of high vector doses can lead to severe side effects with a potentially fatal outcome in individual patients, especially after activation of the immune system.

Abstract

Abstract is not available.

Citation format

HORN, Stefan; FEHSE, B. Wie sicher ist die gentherapie? Innere Medizin, 2024, 65: 617–623.